Symptomatic Hepatocellular Liver Injury With Hyperbilirubinemia in Two Patients Treated With Rivaroxaban-Reference-Cited by-同舟云学术

Symptomatic Hepatocellular Liver Injury With Hyperbilirubinemia in Two Patients Treated With Rivaroxaban

Published:2014-10-01 Issue:10 Volume:174 Page:1683
ISSN:2168-6106
Container-title:JAMA Internal Medicine
language:en
Short-container-title:JAMA Intern Med

Author:

Liakoni Evangelia¹,Rätz Bravo Alexandra E.²,Terracciano Luigi³,Heim Markus⁴,Krähenbühl Stephan¹

Affiliation:

1. Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland

2. Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland2Regional Pharmacovigilance Center, University Hospital Basel, Basel, Switzerland

3. Institute of Pathology, University of Basel, Basel, Switzerland

4. Department of Hepatology and Gastroenterology, University Hospital Basel, Basel, Switzerland

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Severe hepatopathy following rivaroxaban administration in a dog;Frontiers in Veterinary Science;2024-04-04

2. Hepatic Injury due to Drugs, Dietary and Herbal Supplements, Chemicals and Toxins;MacSween's Pathology of the Liver;2024

3. In vivo evaluation of time-dependent antithrombotic effect of rivaroxaban-loaded poly(lactic-co-glycolic acid)/sodium lauryl sulfate or didodecyl dimethylammonium bromide nanoparticles in Wistar rats;European Journal of Pharmaceutics and Biopharmaceutics;2023-09

4. Pharmacokinetics, Bioequivalence, and Safety Evaluation of 2 Formulations of 10‐mg Rivaroxaban Tablets: A 4‐Period Crossover Trial;Clinical Pharmacology in Drug Development;2023-05-21

5. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?;World Journal of Hepatology;2022-04-27